Highly photocytotoxic glucosylated silicon(IV) phthalocyanines. Effects of peripheral chloro substitution on the photophysical and photodynamic properties

Journal of Medicinal Chemistry

Volumn 50, Issue 9, 2007, Pages 2100-2107

  Lo, Pui Chi ^a   Chan, Crystal M H ^a   Liu, Jian Yong ^a   Fong, Wing Ping ^a   Ng, Dennis K P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE DERIVATIVE; N,N DIMETHYLFORMAMIDE; PHTHALOCYANINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SILICON DERIVATIVE;

ARTICLE; CELL STRAIN HEPG2; CELL STRAIN HT29; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORESCENCE; GLYCOSYLATION; HUMAN; HUMAN CELL; IC 50; LYSOSOME; MITOCHONDRION; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHLORINE; DRUG SCREENING ASSAYS, ANTITUMOR; GLYCOSIDES; HUMANS; INDOLES; LYSOSOMES; MITOCHONDRIA; ORGANOSILICON COMPOUNDS; PHOTOSENSITIZING AGENTS; SINGLET OXYGEN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34247568293     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm061415j     Document Type: Article

References (43)

1. Lane, N. New light on medicine. Sci. Am. 2003, 288 (1), 38-45.
2. Dolmans, D. E. J. G. J.; Fukumura, D.; Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380-387.
3. Brown, S. B.; Brown, E. A.; Walker, I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004, 5, 497-508.
4. Castano, A. P.; Mroz, P.; Hamblin, M. R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 2006, 6, 535-545.
5. Detty, M. R.; Gibson, S. L.; Wagner, S. J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 2004, 47, 3897-3915.
6. Ali, H.; van Lier, J. E. Metal complexes as photo- and radiosensitizers. Chem. Rev. 1999, 99, 2379-2450.
7. Oleinick, N. L.; Antunez, A. R.; Clay, M. E.; Rihter, B. D.; Kenney, M. E. New phthalocyanine photosensitizers for photodynamic therapy. Photochem. Photobiol. 1993, 57, 242-247.
8. Huang, J.-D.; Fong, W.-P.; Chan, E. Y. M.; Choi, M. T. M.; Chan, W.-K.; Chan, M.-C.; Ng, D. K. P. Photodynamic activities of a dicationic silicon(IV) phthalocyanine and its bovine serum albumin conjugates. Tetrahedron Lett. 2003, 44, 8029-8032.
9. Lee, P. P. S.; Ngai, T.; Huang, J.-D.; Wu, C.; Fong, W.-P.; Ng, D. K. P. Synthesis, characterization, biodegradation, and in vitro photodynamic activities of silicon(IV) phthalocyanines conjugated axially with poly(e-caprolactone). Macromolecules 2003, 36, 7527-7533.
10. Huang, J.-D.; Wang, S.; Lo, P.-C.; Fong, W.-P.; Ko, W.-H.; Ng, D. K. P. Halogenated silicon(IV) phthalocyanines with axial poly-(ethylene glycol) chains. Synthesis, spectroscopic properties, complexation with bovine serum albumin and in vitro photodynamic activities. New J. Chem. 2004, 28, 348-354.
11. Lo, P.-C.; Huang, J.-D.; Cheng, D. Y. Y.; Chan, E. Y. M.; Fong, W.-P.; Ko, W.-H.; Ng, D. K. P. New amphiphilic silicon(IV) phthalocyanines as efficient photosensitizers for photodynamic therapy: Synthesis, photophysical properties, and in vitro photodynamic activities. Chem.-Eur. J. 2004, 10, 4831-4838.
12. Lee, P. P. S.; Lo, P.-C.; Chan, E. Y. M.; Fong, W.-P.; Ko, W.-H.; Ng, D. K. P. Synthesis and in vitro photodynamic activity of novel galactose-containing phthalocyanines. Tetrahedron Lett. 2005, 46, 1551-1554.
13. Lai, J. C.; Lo, P.-C.; Ng, D. K. P.; Ko, W.-H.; Leung, S. C. H.; Fung, K.-P.; Fong, W.-P. BAM-SiPc, a novel agent for photodynamic therapy, induces apoptosis in human hepatocarcinoma HepG2 cells by a direct mitochondrial action. Cancer Biol. Ther. 2006, 5, 413-418.
14. Lo, P.-C.; Leung, S. C. H.; Chan, E. Y. M.; Fong, W.-P.; Ko, W.-H.; Ng, D. K. P. Photodynamic effects of a novel series of silicon-(IV) phthalocyanines against human colon adenocarcinoma cells. Photodiag. Photodyn. Ther. 2007, in press.
15. Choi, C.-F.; Tsang, P.-T.; Huang, J.-D.; Chan, E. Y. M.; Ko, W.-H.; Fong, W.-P.; Ng, D. K. P. Synthesis and in vitro photodynamic activity of new hexadeca-carboxy phthalocyanines. Chem. Commun. 2004, 2236-2237.
16. Lo, P.-C.; Zhao, B.; Duan, W.; Fong, W.-P.; Ko, W.-H.; Ng, D. K. P. Synthesis and in vitro photodynamic activity of monosubstituted amphiphilic zinc(II) phthalocyanines. Bioorg. Med. Chem. Lett. 2007, 17, 1073-1077.
17. Aoudia, M.; Cheng, G.; Kennedy, V. O.; Kenney, M. E.; Rodgers, M. A. J. Synthesis of a series of octabutoxy- and octabutoxybenzophthalocyanines and photophysical properties of two members of the series. J. Am. Chem. Soc. 1997, 119, 6029-6039.
18. Zamora-Leon, S. P.; Golde, D. W.; Concha, I. I.; Rivas, C. I.; Delgado-Lopez, F.; Baselga, J.; Nualart, F.; Vera, J. C. Expression of the fructose transporter GLUT5 in human breast cancer. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 1847-1852.
19. Medina, R. A.; Owen, G. I. Glucose transporters: expression, regulation and cancer. Biol. Res. 2002, 35, 9-26.
20. Chandler, J. D.; Williams, E. D.; Slavin, J. L.; Best, J. D.; Rogers, S. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 2003, 97, 2035-2042.
21. Godoy, A.; Ulloa, V.; Rodriguez, F.; Reinicke, K.; Yanez, A. J.; Garcia, M. D.; Medina, R. A.; Carrasco, M.; Barberis, S.; Castro, T.; Martinez, F.; Koch, X.; Vera, J. C.; Poblete, M. T.; Figueroa, C. D.; Peruzzo, B.; Perez, F.; Nualart, F. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J. Cell. Physiol. 2006, 207, 614-627.
22. Turro, N. J. Modern Molecular Photochemistry; University Science Books: Sausalito, California, 1991; pp 123-130.
23. Detty, M. R.; Merkel, P. B. Chalcogenapyrylium dyes as potential photochemotherapeutic agents. Solution studies of heavy atom effects on triplet yields, quantum efficiencies of singlet oxygen generation, rates of reaction with singlet oxygen, and emission quantum yields. J. Am. Chem. Soc. 1990, 112, 3845-3855.
24. Krieg, M.; Bilitz, J. M.; Srichai, M. B.; Redmond, R. W. Effects of structural modifications on the photosensitizing properties of dialkylcarbocyanine dyes in homogeneous and heterogeneous solutions. Biochim. Biophys. Acta 1994, 1199, 149-156.
25. Obermuller, R. A.; Hohenthanner, K.; Falk, H. Toward hypericin-derived potential photodynamic therapy agents. Photochem. Photobiol. 2001, 74, 211-215.
26. Pineiro, M.; Gonsalves, A. M. d'A. R.; Pereira, M. M.; Formosinho, S. J.; Arnaut, L. G. New halogenated phenylbacteriochlorins and their efficiency in singlet-oxygen sensitization. J. Phys. Chem. A 2002, 106, 3787-3795.
27. Ramaiah, D.; Eckert, I.; Arun, K. T.; Weidenfeller, L.; Epe, B. Squaraine dyes for photodynamic therapy: mechanism of cytotoxicity and DNA damage induced by halogenated squaraine dyes plus light (>600 nm). Photochem. Photobiol. 2004, 79, 99-104.
28. Gorman, A.; Killoran, J.; O' Shea, C.; Kenna, T.; Gallagher, W. M.; O'Shea, D. F. In vitro demonstration of the heavy-atom effect for photodynamic therapy. J. Am. Chem. Soc. 2004, 126, 10619-10631.
29. Lo, P.-C.; Wang, S.; Zeug, A.; Meyer, M.; Rôder, B.; Ng, D. K. P. Preparation and photophysical properties of halogenated silicon(IV) phthalocyanines substituted axially with poly(ethylene glycol) chains. Tetrahedron Lett. 2003, 44, 1967-1970.
30. Hu, M.; Brasseur, N.; Yildiz, S. Z.; van Lier, J. E.; Leznoff, C. C. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy. J. Med. Chem. 1998, 41, 1789-1802.
31. Maree, M. D.; Kuznetsova, N.; Nyokong, T. Silicon octaphenoxyphthalocyanines: photostability and singlet oxygen quantum yields. J. Photochem. Photobiol., A 2001, 140, 117-125.
32. -2.
33. -2. By using 1 μM of the photosensitizers, the cell survival fraction was found to be about 5-30%.
34. Shen, H. M.; Shi, C. Y.; Shen, Y.; Ong, C. N. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B-1. Free Radical Biol. Med. 1996, 21, 139-146.
35. Linder, S.; Shoshan, M. C. Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resist. Updates 2005, 8, 199-204.
36. Tardy, C.; Codogno, P.; Autefage, H.; Levade, T.; Andrieu-Abadie, N. Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochim. Biophys. Acta 2006, 1765, 101-125.
37. Oleinick, N. L.; Morris, R. L.; Belichenko, I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 2002, 1, 1-21.
38. Schmidt, O. T. Isopropylidene derivatives. In Methods in Carbohydrate Chemistry; Whistler, R. L., Wolfrom, M. L., Eds.; Academic Press: New York, 1963; Vol. II, pp 318-325.
39. Bauer, H.; Stier, F.; Petry, C.; Knorr, A.; Stadler, C.; Staab, H. A. Phenothiazine-bipyridinium cyclophanes. Eur. J. Org. Chem. 2001, 3255-3278.
40. n where M = Si, Ge, and Sn. J. Am. Chem. Soc. 1983, 105, 1539-1550.
41. Eaton, D. F. Reference materials for fluorescence measurement. Pure Appl. Chem. 1988, 60, 1107-1114.
42. Ferraudi, G. Photochemical properties of metallophthalocyanines in homogeneous solution. In Phthalocyanines-Properties and Applications; Leznoff, C. C., Lever, A. B. P., Eds.; VCH: New York, 1989; Vol. 1, p 301.
43. Tada, H.; Shiho, O.; Kuroshima, K.; Koyama, M.; Tsukamoto, K. An improved colorimetric assay for interleukin-2. J. Immunol. Methods 1986, 93, 157-165.